Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Bruker (BRKRP) over the last 13 years, with Q4 2024 value amounting to $271477.0.

  • Bruker's Gains from Sales and Divestitures rose 190.77% to $271477.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $271477.0, marking a year-over-year increase of 190.77%. This contributed to the annual value of $271477.0 for FY2024, which is 190.77% up from last year.
  • Latest data reveals that Bruker reported Gains from Sales and Divestitures of $271477.0 as of Q4 2024, which was up 190.77% from $266395.0 recorded in Q4 2023.
  • In the past 5 years, Bruker's Gains from Sales and Divestitures ranged from a high of $336728.0 in Q4 2020 and a low of $41738.0 during Q1 2020
  • For the 4-year period, Bruker's Gains from Sales and Divestitures averaged around $225210.5, with its median value being $273279.5 (2022).
  • In the last 5 years, Bruker's Gains from Sales and Divestitures soared by 3270.82% in 2020 and then tumbled by 522.99% in 2023.
  • Over the past 4 years, Bruker's Gains from Sales and Divestitures (Quarter) stood at $336728.0 in 2020, then dropped by 16.52% to $281096.0 in 2022, then dropped by 5.23% to $266395.0 in 2023, then grew by 1.91% to $271477.0 in 2024.
  • Its last three reported values are $271477.0 in Q4 2024, $266395.0 for Q4 2023, and $281096.0 during Q4 2022.